World's leading clinical conference on bone, joint and muscle health
Programme Sponsored sessions
Thursday April 10 th - CEST Timezone
19:10 - 20:10
Contura Sponsored Welcome Cocktail
Friday April 11 th - CEST Timezone
08:00
Opening of the Congress & commercial exhibition
08:00 - 09:00
Auditorium B
Gedeon Richter Sponsored Breakfast Satellite Symposium - Restoring Bone Strength: It Takes Two to Dance a Tango
Chairpersons: Serge Ferrari, Salvatore Minisola
Chairpersons: Serge Ferrari, Salvatore Minisola
08:00
Auditorium B
Welcome & introduction
08:05
Auditorium B
Targeting the structural determinants of bone fragility
08:30
Auditorium B
Clinical benefits of sequential and combination therapies with teriparatide and anti-resorptives
08:55
Auditorium B
Discussion and Q&A
12:15 - 13:45
Auditorium A
UCB Sponsored Lunch Satellite Symposium: Romosozumab: Right patient, right time
Chairperson: Salvatore Minisola
Chairperson: Salvatore Minisola
12:15
Auditorium A
A defining era in osteoporosis management
12:25
Auditorium A
Rethinking bone building with romosozumab
12:40
Auditorium A
Optimising outcomes with romosozumab first
13:00
Auditorium A
Recognising the opportunity with romosozumab
13:20
Auditorium A
Faculty Q&A
13:40
Auditorium A
Looking to a stronger future
12:15 - 13:45
Auditorium B
Viatris Sponsored Lunch Satellite Symposium: Advancing Osteoarthritis Care: Integrating Early Intervention, Multimodal Approaches, and Patient-Centered Management
Chairperson: Jean-Yves Reginster
Chairperson: Jean-Yves Reginster
12:15
Auditorium B
Rising OA Incidence: Early Intervention and SYSADOAs for Effective Management
12:15
Auditorium B
From Pain to Precision: Choosing an NSAID for Osteoarthritis Management
12:15
Auditorium B
Integrating Multimodal Approaches for Comprehensive OA Management
14:00 - 15:00
MR5
Promedius Sponsored Honorary Lecture: Discovering New Horizons in Bone Health with Artificial Intelligence
Chairpersons: Jean-Yves Reginster, Nicholas Fuggle
Chairpersons: Jean-Yves Reginster, Nicholas Fuggle
14:05
MR5
Introduction of a chest X-ray based opportunistic osteoporosis screening AI solution
14:20
MR5
Cost-effectiveness analysis of opportunistic osteoporosis screening using chest X-ray
14:35
MR5
Journey to find optimal fracture risk prediction model based on chest X-rays
14:50
MR5
Panel discussion
17:00 - 18:30
Auditorium A
Echolight Sponsored Satellite Symposium - REMS early diagnoses as effective strategies for fracture prevention
Chairpersons: Jean-Yves Reginster, Nicholas Harvey
Chairpersons: Jean-Yves Reginster, Nicholas Harvey
17:15
Auditorium A
REMS technology for fracture prevention
17:30
Auditorium A
REMS suitability in secondary osteoporosis
17:45
Auditorium A
Bone health management in pregnancy
18:00
Auditorium A
Economic Benefits of REMS
18:15
Auditorium A
REMS: Bone density assessment without ionising radiation - an alternative to DXA?
Saturday April 12 th - CEST Timezone
08:00 - 09:00
Auditorium B
Sandoz Sponsored Breakfast Satellite Symposium - Biosimilar Denosumab from Theory to Practice: Opportunity, Evidence and First Real-World Experience
Chairperson: Richard Eastell
Chairperson: Richard Eastell
08:00
Auditorium B
Welcome and introduction
08:05
Auditorium B
Treatment gaps in osteoporosis and 78-week data from the ROSALIA study of biosimilar denosumab
08:25
Auditorium B
Realizing the opportunity: informational needs and real-world switch experience in Canada
08:45
Auditorium B
Q&A Session
08:55
Auditorium B
Closing remarks
12:15 - 13:45
Auditorium A
Theramex Sponsored Lunch Satellite Symposium: Abaloparatide▼ in Postmenopausal Osteoporosis Women: Real-World Evidence and Clinical Approaches
Chairperson: Jean-Yves Reginster
Chairperson: Jean-Yves Reginster
12:15
Auditorium A
Welcome and Opening Remarks
12:20
Auditorium A
Real-World Evidence in Abaloparatide Therapy: Insights and Implications for Clinical Practice
12:50
Auditorium A
Abaloparatide in Action: Patient Profile and Treatment Protocols
13:00
Auditorium A
Abaloparatide in Action: Patient Profile and Treatment Protocols
13:10
Auditorium A
Panel Discussion: Are PTH (Parathyroid Hormone) agonists similar or different? Insights from Experts
13:35
Auditorium A
Question & Answers
12:15 - 13:45
Auditorium B
Amgen Sponsored Lunch Satellite Symposium: Is a Treat to Target (T2T) approach realistic in osteoporosis patients at high fracture risk?
Chairperson: Serge Ferrari
Chairperson: Serge Ferrari
12:15
Auditorium B
Introduction
12:20
Auditorium B
Lessons from T2T strategies in rheumatic disorders
12:40
Auditorium B
T2T in current task forces/guidelines: Where are we now?
13:00
Auditorium B
Can we achieve a long-term goal in OP with current drugs?
13:20
Auditorium B
Panel Discussion and audience Q&A
13:40
Auditorium B
Closing Remarks
Sunday April 13 th - CEST Timezone
09:00 - 10:00
MR5
Alexion Sponsored Meet-The-Expert Session: Could It Be Hypophosphatasia (HPP)? A Conversation With Experts
Chairpersons: Maria Luisa Brandi, Lothar Seefried
Chairpersons: Maria Luisa Brandi, Lothar Seefried
09:00
MR5
Welcome and introductions
09:05
MR5
Overview of HPP in adults from an endocrinologist’s perspective
09:20
MR5
Challenges in HPP management
09:35
MR5
Practical approaches to multidisciplinary HPP management: Interactive discussions and questions from the audience
09:55
MR5
Conclusions and summary